Citadel Advisors
ONXX

Citadel Advisors’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Citadel Advisors’s Portfolio ONXX Stock Details ONXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-519,800
Closed -$64.8M – 7481
2013
Q3 		$64.8M Buy
519,800
+453,000
+678% +$57.4M 0.1% 215
2013
Q2 		$5.8M Buy
+66,800
New +$6.15M 0.01% 1440

Citadel Advisors's ONXX Position: Q4 2013 in Review

Citadel Advisors sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q4 2013, closing a stake of 2,340 shares — an estimated $291K sold.

Citadel Advisors first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $59.6M in Q2 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.

  • Citadel Advisors reported no remaining ONYX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Citadel Advisors sold 2,340 ONYX PHARMACEUTICALS INC shares in Q4 2013, an estimated $291K.
  • Citadel Advisors first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Citadel Advisors's ONYX PHARMACEUTICALS INC position peaked at $59.6M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q4 2013.

Based on Citadel Advisors's 13F filing for Q4 2013, filed 14 Feb 2014.